Infectious Disease · Elmhurst, NY
NPI
1982047833
Since 2013
Specialty
Infectious Disease
Code 390200000X
Group practices
3
Medicare group memberships
Hospitals
1
Hospital affiliations
7901 Broadway, Dept of Internal Medicine
Elmhurst, NY, 11373
Phone (831) 566-8332
Groups this clinician bills Medicare through
Medicare paid, 2024
$2,582
26 services
Medicare patients, 2024
24
Average age 71
Drug cost, 2024
$3.3M
3,625 prescriptions
Company payments, 2025
$26.56
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Alexander Lafortune was code 99222 (hospital e&m - initial), 11 times for 11 patients. In total Alexander Lafortune billed 26 services in 6 codes, and Medicare paid $2,582.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-03-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99222 Hospital E&M - Initial | Facility | 11 | 11 | $116.10 | $1,277 |
By year: 2022 $4,704 for 58 services; 2023 $4,824 for 56 services; 2024 $2,582 for 26 services.
Medicare prescription drug claims, 2024
In 2024, the drug Alexander Lafortune prescribed most often to Medicare patients was Atorvastatin Calcium, with 244 prescriptions and refills. In total Alexander Lafortune wrote 3,625 Medicare prescriptions that cost $3.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 244 | 364 | 42 | $1,933 |
| Tivicay Dolutegravir Sodium | 192 | 208 | 23 | $455K |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 180 | 184 | 31 | $691K |
| Amlodipine Besylate Generic | 172 | 290 | 35 | $897 |
| Odefsey Emtricitab/Rilpiviri/Tenof Ala | 134 | 138 | 14 | $477K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 127 | 136 | 22 | $3,996 |
| Tamsulosin Hcl Generic | 111 | 139 | 20 | $650 |
| Lisinopril Generic | 100 | 186 | 24 | $451 |
| Juluca Dolutegravir/Rilpivirine | 90 | 98 | 11 | $325K |
| Rosuvastatin Calcium Generic | 89 | 119 | 15 | $1,124 |
| Metformin Hcl Generic | 75 | 133 | 16 | $319 |
| Famotidine Generic | 71 | 77 | 11 | $454 |
| Omeprazole Generic | 71 | 79 | Under 11 | $238 |
| Symtuza Darunavir/Cob/Emtri/Tenof Alaf | 69 | 83 | Under 11 | $359K |
| Genvoya Elviteg/Cob/Emtri/Tenof Alafen | 67 | 71 | Under 11 | $266K |
Brand drugs: 1,388 claims; generic drugs: 2,145 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Alexander Lafortune $26.56 ($26.56 in general payments such as food, travel and fees) from 1 company. The largest payer was Gilead Sciences, Inc. with $26.56.
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. GILD | 1 | $26.56 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.